Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening in Alzheimer's disease patients
Sponsor: |
National Institute on Aging NIA |
Enrolling: |
Male and Female Patients |
Study Length: |
4 Months |
Clinic Visits: |
5 |
IRB Number: |
AAAS5163 |
U.S. Govt. ID: |
NCT04118764 |
Contact: |
Elisa E. Konofagou: 212-342-0863 / ek2191@columbia.edu |
A clinical trial that uses focused ultrasound to non-invasively open the blood-brain barrier in Alzheimer's disease patients, in order to help get medication into their brain. In this study, we will focus on the safety and efficacy of this technique, without the use of an anti-Alzheimer's drug. We will also test whether treatment with focused ultrasound alone alters the amyloid protein levels in the treated brain areas and its potential effects on the cognitive function of Alzheimer's patients.
This study is closed
Investigator
Elisa Konofagou, PhD
Are you 50 years of age or older? |
Yes |
No |
Are you diagnosed with Alzheimer's Disease? |
Yes |
No |
Are you able to provide informed consent? |
Yes |
No |